NIH-funded research R01 grant

Investigating how specific proteins affect kidney disease

Official title: Role of the Factor H Related Proteins in Kidney Disease

Funded at University of Colorado Denver · NIH-11058515 · Data updated 2026-11-12

This study is looking at how certain proteins in the body affect kidney diseases, especially those caused by the immune system, to help find new ways to treat these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startApril 1, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$481,125
NIH project number5R01DK138960-02
Project IDNIH-11058515 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with autoimmune kidney diseases or those affected by conditions related to complement system dysregulation.

Less likely to help

Patients with kidney diseases unrelated to the complement system or those who do not have autoimmune conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of Factor H-related proteins in kidney diseases, particularly autoimmune glomerulonephritis. It aims to explore how these proteins regulate the complement system, which is crucial for immune responses in the kidneys. By using animal models and monoclonal antibodies, the study will investigate how these proteins interact with complement activation and inflammation in kidney tissues. This could lead to new insights into the mechanisms of kidney disease and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for various kidney diseases by targeting specific proteins involved in immune regulation.

How similar studies have gone: Previous research has shown that targeting components of the complement system can lead to significant advancements in treating autoimmune diseases, suggesting a promising avenue for this investigation.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Thurman, Joshua M — University of Colorado Denver
  • Study coordinator: Thurman, Joshua M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.